Real-time Estimate Tradegate 10:20:51 2024-05-21 am EDT 5-day change 1st Jan Change
269.6 EUR -0.15% Intraday chart for Sartorius AG -7.08% -19.27%
LockThis Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
SARTORIUS VORZUEGE : Jefferies sticks Neutral ZD
SARTORIUS VORZUEGE : Deutsche Bank sticks Neutral ZD
SARTORIUS VORZUEGE : Warburg Research sticks Neutral ZD
SARTORIUS VORZUEGE : Barclays remains Neutral ZD
German Shares Close Lower as ECB Keeps 'Fragile' Outlook MT
Sartorius Partners with Nvidia on Drug Discovery, Manufacturing Using AI MT
Sartorius sinks again towards year low DP
SARTORIUS VORZUEGE : UBS remains Neutral ZD
Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day
Sartorius Partners With Sanofi for Biomanufacturing Platform MT
SARTORIUS : Target cut by -6.1% Alphavalue
SARTORIUS VORZUEGE : Gets a Buy rating from Berenberg ZD
SARTORIUS VORZUEGE : DZ Bank gives a Sell rating ZD
US competitor Danaher boosts Merck KGaA and Sartorius DP
SARTORIUS VORZUEGE : Barclays remains Neutral ZD
SARTORIUS VORZUEGE : Deutsche Bank remains Neutral ZD
JPMorgan lowers target for Sartorius to 340 euros - 'Overweight' DP
SARTORIUS : Q1 24: Top-line miss but a few positives Alphavalue
SARTORIUS VORZUEGE : JP Morgan reiterates its Buy rating ZD
SARTORIUS VORZUEGE : Deutsche Bank reaffirms its Neutral rating ZD
German Shares Close Green as Bundesbank Sees Q1 Economic Growth MT
SARTORIUS VORZUEGE : Barclays remains Neutral ZD
FTSE 100 up despite hawkish Fed rates outlook AN
Sartorius continues recovery after weak start - share price slide DP
SARTORIUS VORZUEGE : Warburg Research reiterates its Neutral rating ZD
Chart Sartorius AG
More charts
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
270 EUR
Average target price
326.8 EUR
Spread / Average Target
+21.02%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW